| Literature DB >> 29087045 |
Oren Miron1, Andrew L Beam1, Isaac S Kohane1.
Abstract
Infants with autism spectrum disorder (ASD) were recently found to have prolonged auditory brainstem response (ABR); however, at older ages, findings are contradictory. We compared ABR differences between participants with ASD and controls with respect to age using a meta-analysis. Data sources included MEDLINE, EMBASE, Web of Science, Google Scholar, HOLLIS, and ScienceDirect from their inception to June 2016. The 25 studies that were included had a total of 1349 participants (727 participants with ASD and 622 controls) and an age range of 0-40 years. Prolongation of the absolute latency of wave V in ASD had a significant negative correlation with age (R2 = 0.23; P = 0.01). The 22 studies below age 18 years showed a significantly prolonged wave V in ASD (Standard Mean Difference = 0.6 [95% CI, 0.5-0.8]; P < 0.001). The 3 studies above 18 years of age showed a significantly shorter wave V in ASD (SMD = -0.6 [95% CI, -1.0 to -0.2]; P = 0.004). Prolonged ABR was consistent in infants and children with ASD, suggesting it can serve as an ASD biomarker at infancy. As the ABR is routinely used to screen infants for hearing impairment, the opportunity for replication studies is extensive. Autism Res 2018, 11: 355-363.Entities:
Keywords: auditory; biomarker; children; event related potential; infants
Mesh:
Year: 2017 PMID: 29087045 PMCID: PMC5836986 DOI: 10.1002/aur.1886
Source DB: PubMed Journal: Autism Res ISSN: 1939-3806 Impact factor: 5.216
Figure 1Inclusion of studies in meta‐analysis.
Characteristics of the 25 Included Studies
| Study (1st author) |
Age | Sample (N) | Male (%) | Intensity (dB nHL) | Rate (clicks/sec) | Sweeps (trials) | Publication (year) | Polarity |
|---|---|---|---|---|---|---|---|---|
| Cohen | 0.0 | 70 | 59 | 80 | 12.9 | 3,072 | 2013 | Rarefaction |
| Miron | 0.1 | 60 | 80 | 85 | 39.1 | 2,000 | 2015 | Alternating |
| Dabbous | 2.4 | 50 | 66 | 90 | 27.5 | N/A | 2012 | Rarefaction |
| Roth | 2.6 | 52 | 83 | 85 | 39.1 | 2,000 | 2012 | Alternating |
| Kwon | 3.3 | 121 | 82 | 90 | 13 | N/A | 2007 | N/A |
| Wong | 3.4 | 129 | 72 | 80 | 10 | 2,048 | 1991 | Rarefaction |
| Tas | 3.9 | 42 | 75 | 80 | 16 | 2,000 | 2007 | Alternating |
| Ververi | 4.0 | 86 | 100 | 70 | N/A | 2,048 | 2015 | N/A |
| Azouz | 5.0 | 45 | 76 | N/A | N/A | N/A | 2014 | N/A |
| Tanguay | 5.5 | 28 | 86 | 72 | 20 | 1,500 | 1982 | Rarefaction |
| Tharpe | 5.7 | 36 | 90 | 80 | 21.1 | 2,000 | 2006 | Alternating |
| Ornitz | 6.0 | 15 | N/A | 68 | 10 | 1,024 | 1980 | Rarefaction |
| Sohmer | 7.5 | 31 | N/A | 75 | 15 | 1,024 | 1978 | N/A |
| Student | 8.0 | 24 | N/A | 75 | 10 | N/A | 1978 | Alternating |
| Rosenhall (female) | 9.6 | 54 | 0 | 80 | 22.5 | 1,012 | 2003 | Alternating |
| Russo | 9.8 | 39 | 73 | N/A | 13 | 3,000 | 2009 | N/A |
| Rosenblum | 9.8 | 12 | 67 | 60 | 10 | 1,000 | 1980 | N/A |
| Skoff | 10.3 | 36 | 53 | 60 | 10 | 2,000 | 1980 | N/A |
| Rosenhall (male) | 10.3 | 106 | 100 | 80 | 22.5 | 1,012 | 2003 | Alternating |
| Fujikawa‐Brooks | 10.8 | 40 | 88 | 75 | 19 | 1,024 | 2010 | Alternating |
| Gillberg | 11.3 | 55 | 65 | 80 | N/A | 2,048 | 1983 | Alternating |
| Sersen | 11.5 | 83 | 100 | 50 | 10.3 | 1,500 | 1990 | Rarefaction |
| Magliaro | 12.1 | 41 | 65 | 80 | 19 | 2,000 | 2010 | Rarefaction |
| Rumsey | 19.4 | 50 | 92 | 80 | 11 | 2,048 | 1984 | Rarefaction |
| Courchesne | 19.6 | 28 | 86 | 70 | 37 | 2,750 | 1985 | Rarefaction |
| Grillon | 21.7 | 16 | 100 | 70 | 7 | 2,000 | 1989 | Rarefaction |
|
|
|
|
|
|
|
| ||
Both studies used preterm infants in ASD and control groups.
ASD participants overlap between both studies.
ASD participants overlap between studies. N/A‐Not Available. NS‐Non significant weighted linear regression (p > 0.05), expect for Polarity which used a T‐test; dB nHL‐ Decibels above Normal Hearing Level.
Figure 2Correlation of wave V ASD prolongation and age. Legend: Y = Wave V ASD prolongation in percentage. X = mean age at time of ABR in years. Blue line = Linear regression. Grey area = Linear regression confidence interval of 95%. White names indicate first author name and circle size corresponds to sample size. For example, Circle “Cohen” represents Cohen et al. [2013] and the size corresponds to a sample size of 70 participants.
Figure 3Correlation of IPL I–V ASD prolongation and age. Legend: Y = IPL I–V ASD prolongation in percentage. X = mean age at time of ABR in years. Blue line = Linear regression. Grey area = Linear regression confidence interval of 95%. White names indicate first author name and circle size corresponds to sample size. For example, Circle “Cohen” represents Cohen et al. [2013] and the size corresponds to a sample size of 70 participants.
Figure 4Forest plot of ASD prolongation. Legend: Study (first author), year (publication); Age (mean in years); Sample (combined for ASD and controls); V‐ Wave V latency; SD‐ Standard Deviation; Black square indicates SMD and error bars indicate confidence interval of 95%, which are indicated numerically under ASD Prolongation [95% CI]. Square size indicates the proportional weight of the study on the combined SMD.